Atherosclerosis is the leading cause of heart disease, contributing to hundreds of thousands
of deaths annually. The use of long-term antilipid therapy has decreased low-density …

High-density lipoproteins (HDL) have received considerable interest as a target for the
development of novel anti-atherosclerotic agents beyond conventional approaches to lipid …

Acute high-density lipoprotein therapies : Current Opinion in Lipidology Acute high-density
lipoprotein therapies : Current Opinion in Lipidology Log in or Register Subscribe to journalSubscribe …

Atherothrombosis, atherosclerosi, s and their thrombotic complications have become
epidemic. Both an elevated low-density lipoprotein (LDL) cholesterol level and a decreased …

ContextHigh-density lipoprotein (HDL) cholesterol is an inverse predictor of coronary
atherosclerotic disease. Preliminary data have suggested that HDL infusions can induce …

Studies have shown a reduction in plaque volume and change in plaque ultrasound
characteristics after 4 infusions of reconstituted high-density lipoprotein (rHDL). Whether …

The development of atherosclerosis is a complex process whose central elements include
the entrapment of low-density lipoprotein in the vessel wall, its subsequent oxidative …

Despite considerable progress in the development of new therapies to control
atherosclerosis and its complications, coronary heart disease (CHD) remains the number …

High-density lipoprotein (HDL) plays a key role in reverse cholesterol transport but also
activates nitric oxide synthase and stimulates prostacyclin release, enhances endothelial …

The field of high-density lipoprotein (HDL) therapeutics is broadly aimed at combating the
significant residual cardiovascular risk remaining after effective low-density lipoprotein (LDL) …